A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same as the weight loss and diabetes drugs Ozempic and Wegovy…. Read More
The post Hims & Hers class action alleges semaglutide GLP-1 products falsely advertised appeared first on Top Class Actions.
Get the latest on Mass Torts and Class Actions right in your inbox. Subscribe to our newsletter for key updates and insights. Quick, informative, and essential for staying ahead.
Get notified for our latest news on Mass Torts and Class Action Lawsuits.
We scour the internet to bring you the most relevant and recent updates in the world of mass torts and class actions.
